Sarepta Therapeutics, Inc. - Common Stock (NQ:SRPT)
17.92
-0.30
(-1.65%)
Streaming Delayed Price
Updated: 10:20 AM EDT, Aug 12, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 207,398 |
| Open | 18.06 |
| Bid (Size) | 17.90 (4,000) |
| Ask (Size) | 17.92 (300) |
| Prev. Close | 18.22 |
| Today's Range | 17.87 - 18.20 |
| 52wk Range | 14.68 - 25.32 |
| Shares Outstanding | 93,148,652 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
2 Beaten-Down Stocks That Still Aren't Worth Buying ↗
July 11, 2026
My Top 3 Biotech Stocks for May 2026 ↗
May 20, 2026
Sarepta (SRPT) Q1 2026 Earnings Transcript ↗
May 06, 2026
Frequently Asked Questions
Is Sarepta Therapeutics, Inc. - Common Stock publicly traded?
Yes, Sarepta Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Sarepta Therapeutics, Inc. - Common Stock trade on?
Sarepta Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sarepta Therapeutics, Inc. - Common Stock?
The ticker symbol for Sarepta Therapeutics, Inc. - Common Stock is SRPT on the Nasdaq Stock Market
What is the current price of Sarepta Therapeutics, Inc. - Common Stock?
The current price of Sarepta Therapeutics, Inc. - Common Stock is 17.92
When was Sarepta Therapeutics, Inc. - Common Stock last traded?
The last trade of Sarepta Therapeutics, Inc. - Common Stock was at 08/12/26 10:20 AM ET
What is the market capitalization of Sarepta Therapeutics, Inc. - Common Stock?
The market capitalization of Sarepta Therapeutics, Inc. - Common Stock is 1.67B
How many shares of Sarepta Therapeutics, Inc. - Common Stock are outstanding?
Sarepta Therapeutics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.